Unplanned hold time extension during tech transfer – root cause analysis failure explained







Published on 05/01/2026

Further reading: Manufacturing Deviation Case Studies

Analyzing Unplanned Hold Time Extensions During Tech Transfers: A Comprehensive Case Study

Unplanned hold time extensions during technical transfers can pose significant risks to pharmaceutical manufacturing, raising concerns about product quality, compliance with GMP, and regulatory inspection readiness. This case study illustrates a realistic scenario of a manufacturing deviation, detailing the symptoms observed on the production floor, potential causes, immediate containment actions, investigative workflows, and ultimately, the corrective and preventive actions taken. By understanding the detailed steps of this process, pharmaceutical professionals can enhance their operational integrity and readiness for regulatory scrutiny.

If you want a complete overview with practical prevention steps, see this Manufacturing Deviation Case Studies.

Upon completing this article, readers will be equipped with comprehensive knowledge on managing unplanned hold time extensions. This will empower teams to systematically address deviations and bolster

inspection preparedness by ensuring all critical areas have been suitably addressed.

Symptoms/Signals on the Floor or in the Lab

The first signs of a potential problem may surface on the manufacturing floor or within the laboratory setting. In our case study, the following symptoms were identified:

  • Increased Hold Time: The process involved an unplanned extension of the hold time for an active pharmaceutical ingredient (API). The original hold time was 30 minutes, which extended to over 90 minutes without appropriate documentation or approval.
  • Documentation Gaps: Operators noted that batch records did not reflect the extended hold time, creating discrepancies in data integrity.
  • Quality Assurance Alerts: The Quality Assurance (QA) team received alerts triggered by the monitoring system, indicating that hold conditions were not maintained within established parameters for a critical step in the process.
  • Deviations in Product Characteristics: Subsequent analysis of batches processed under these conditions indicated potential variances in impurity profiles, raising alarms regarding product consistency.

These symptoms pointed towards a serious deviation that required immediate attention to avoid compounding the issue.

Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

To effectively address the unplanned hold time extension, it is imperative to categorize potential causes through the lens of the 6 M’s framework: Materials, Method, Machine, Man, Measurement, and Environment.

1. Materials

Variability in raw materials, especially concerning stability profiles of APIs, may lead to changes in processing parameters, thereby necessitating longer holds. Quality assurance on material procurement should be heightened to ensure that all materials meet the strictest specifications.

2. Method

The operational protocol for the transfer may have inherent weaknesses, such as inadequately defined hold times. Failure to adapt processes in accordance with real-time observations could exacerbate situations like this.

Pharma Tip:  Critical IPC skipped during changeover – root cause analysis failure explained

3. Machine

Equipment malfunctions or delays in maintenance can contribute to extended hold times. A systematic review of machine calibration records is essential to identify trends indicating malfunctions.

4. Man

Human error during operation or insufficient training may lead to improper execution of standard operating procedures (SOPs), directly contributing to deviations in hold times.

5. Measurement

Inaccurate instrumentation or failure to comply with control measures may skew data on process parameters, leading operators to make ill-informed decisions regarding hold times.

6. Environment

Fluctuations in environmental conditions, such as temperature and humidity, can impact the stability of the process, prompting variations that necessitate extended hold durations.

Immediate Containment Actions (first 60 minutes)

In the wake of identifying the issue, immediate containment actions were critical to mitigate the risks associated with the unplanned hold time extension:

  • Stopping All Production: All ongoing batch processing linked to the extended hold was halted to prevent potential adverse effects on product quality.
  • Segregation of Affected Batches: All materials linked to the affected batch were segregated and clearly labeled in accordance with the company’s isolation procedures.
  • Team Mobilization: A cross-functional team of quality assurance, production, and engineering personnel was convened immediately to initiate corrective actions and begin the investigation.
  • Documentation Review: An immediate review of all batch records and operating logs was conducted to track the timeline and actions leading up to the extension occurrence.

Investigation Workflow (data to collect + how to interpret)

A structured investigation workflow is crucial for identifying the root causes effectively. The following data were collected during the investigation:

  • Batch Records: Complete documentation of the affected batch, including timestamps, temperature profiles, and deviations recorded.
  • Equipment Logs: Records of machine operations, calibration, and maintenance to assess if equipment contributed to the extended hold time.
  • Operator Interviews: Gather firsthand accounts from operators and QA personnel regarding their actions and any observed anomalies in the process.
  • Environmental Monitoring Data: Historical data on temperature and humidity levels during the critical hold period to evaluate external influences.

Interpreting this data involved creating timelines to link actions and variables to the moment of deviation. The team also focused on identifying any conflicting data, such as logs that did not correlate with operator statements or observed process outcomes.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

To uncover the underlying reasons behind the unplanned hold time extension, the following root cause analysis tools were implemented:

1. 5-Why Analysis

This tool was employed first due to its straightforward approach. Starting with the symptom, the team asked “why” iteratively to drill down to find deeper causes. For instance:

  • Why was there an unplanned hold? Because the staff was unsure if parameters were met.
  • Why were they unsure? Lack of clarity in the established hold time.
  • Why was that lacking? The SOP was not updated with recent changes.
Pharma Tip:  Batch executed with expired SOP during commercial campaign – root cause analysis failure explained

2. Fishbone Diagram

This tool facilitated broader discussions among stakeholders, allowing them to visualize multiple causes arising from the 6 M’s. It helped in classifying contributory causes under distinct categories for better understanding and management.

3. Fault Tree Analysis

Finally, fault tree analysis provided a systematic, logical method to analyze the event’s possibilities and pinpoint critical failure paths that led to the extended hold time. This approach is particularly helpful when multiple factors intertwine to cause a deviation.

CAPA Strategy (correction, corrective action, preventive action)

Identifying the root causes of a deviation is essential, but the real challenge lies in effectively implementing corrective and preventive actions (CAPA). Here’s how the CAPA process was structured:

Related Reads

1. Correction

This initial stage involved documenting the extension and ensuring immediate corrective actions were confirmed and that the affected batch was either reprocessed or discarded per GMP standards.

2. Corrective Action

Subsequent actions involved revising SOPs to reflect new industry learnings, enhancing training sessions for operators to bridge knowledge gaps, and increasing the frequency of equipment maintenance checks.

3. Preventive Action

To mitigate future occurrences, the team initiated a routine review process to audit operating conditions continuously. The implementation of additional monitoring systems (alarms for hold time thresholds) and training programs was also crucial for reinforcing personnel awareness.

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

Upon addressing the corrective measures, the next step is to develop a robust control strategy:

  • Statistical Process Control (SPC): Implementing SPC techniques to evaluate real-time data trends of hold times, including control charts to recognize deviations immediately.
  • Sampling Plan Optimization: Revising sampling plans to include more points before and after hold times to assess their effects on product quality more accurately.
  • Alarm Systems: Establishing alarm thresholds for hold times, which notifies operators in real-time when hold times deviate from established protocols.
  • Verification Protocols: Instituting periodic review and verification points to confirm whether the corrective actions taken are effective and that the parameters are continually adhered to in routine operations.

Validation / Re-qualification / Change Control impact (when needed)

In light of the CAPA actions instituted, it became necessary to assess any implications on validation, re-qualification processes, or change controls. Due to the extension impacting product quality and characterization:

  • Re-qualification: A complete re-qualification of the impacted processes must be conducted, ensuring that all validation data reflects the current procedures.
  • Change Control Registrations: Any SOP amendments must be processed through the established change control system to ensure compliance with regulatory expectations and internal governance.

Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

For regulatory agencies such as the FDA, EMA, and MHRA, demonstrating inspection readiness requires thorough documentation of the deviation management process. Collectively, the evidence must include:

  • Batch Records: All documentation pertaining to the batch in question, including unexpected extensions and operator actions.
  • Equipment Logs: Detailed records showcasing maintenance, calibrations, and any errors reported by the machinery.
  • Investigation Reports: Summarized findings from the investigation, including root cause analysis and action items and responsibilities.
  • Training Records: Evidence of any staff retraining or refresher sessions conducted in light of lessons learned.
Pharma Tip:  Equipment used without release during routine manufacturing – FDA inspection observation breakdown

These documents should all be readily available and organized for review during any regulatory inspection to demonstrate that the firm is committed to upholding GMP standards and operational excellence.

FAQs

What are common symptoms that signal a hold time issue?

Common symptoms include increased production timeline, discrepancies in documentation, QA alerts, and changes in product characteristics.

How can I ensure compliance with GMP during a deviation?

Adherence to SOPs, comprehensive documentation, and follow-through on corrective actions and preventive measures are critical to maintain compliance.

What immediate actions should be taken upon discovering a deviation?

Cease production, segregate affected materials, convene a cross-functional response team, and initiate immediate documentation review.

When should we perform a root cause analysis?

A root cause analysis should be undertaken as soon as a deviation is confirmed to prevent reoccurrence and support continuous improvement.

Which CAPA actions are most effective for preventing future deviations?

Effective CAPA actions include revising SOPs, enhancing training, rigorous pre-production checks, and real-time monitoring integrations.

What monitoring systems should we implement post-deviation?

Implement statistical process control for trending, proactive sampling strategies, alarm systems for irregularities, and verification schedules for effective monitoring.

What is the role of change control in deviations?

Change control ensures that all process changes get documented, reviewed, and approved, confirming that they will not negatively impact product quality.

How often should training be conducted to ensure operator competency?

Regular training sessions should take place, particularly after any changes in procedures or following the identification of a deviation, alongside annual refresher courses.

How important is documentation in a regulatory inspection?

Documentation is critical as it provides evidence of compliance, effective management, and continuous improvement processes during regulatory inspections.

When should a re-qualification process be initiated?

Re-qualification should be initiated whenever changes in processes occur that may impact product quality or compliance with established specifications.

What preventive strategies can be established post-deviation analysis?

Preventive strategies include comprehensive reviews of existing procedures, regular audits, and training to ensure personnel are informed and compliant with new methodologies.

What regulatory authorities should we be prepared for during inspections?

Prepare for inspections from the FDA in the US, EMA in Europe, and MHRA in the UK amongst other authorities to ensure broad compliance with global standards.